STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom ...

Market Growing for Custom-Made Peptides July 1, 2006 July 1, 2006 (Vol. 26, No. 13) Expansion Attributed to Increased Use in Drug and Vaccine Development Continued growth and a changing landscape ...

Peptide synthesis is no longer just a laboratory utility, growing at a CAGR of over 8%. Within this sector, biotinylation—the process of covalently attaching biotin to a peptide—represents one of the ...

Biosynth announced an automated peptide quotation tool for customers with a web account, allowing customers to instantly generate a custom peptide quote. The company notes that the tool was designed ...

The peptide boom is under scrutiny as the FDA weighs easing restrictions on several drugs in the category. Peptides, which are short chains of amino acids that serve as the building blocks of proteins ...

The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug ...

Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom peptide revolution. Automated Custom ...